Featured
Last news
Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND
Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1's upcoming IND submission for a rare disease indication
Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's In Response To Additional Shareholder Questions
AUSTIN, TEXAS / ACCESS Newswire / May 21, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ's on its investor website in response to shareholder questions around its AGM date and other corporate actions.
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company agreed to issue to investors unregistered warrants to purchase up to 492,612 shares of common stock at an exercise price of $5.84 per share that will be immediately exercisable upon issuance and will expire on the earlier of (i) 24 months from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event. The closing of the offering is expected to occur on or about May 22, 2025, subject to the satisfaction of customary closing conditions.
Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000
Regenerative Medical Technologies Group, Inc. $RMTG, a regenerative medicine company, is pleased to announce that sales for its first quarter of 2025 surpassed $1.35M and achieved operational profits of $134,000 for the quarter.
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings.
Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA) for mRNA-1083, its flu/COVID combination vaccine candidate for adults aged 50 years and older. The Company plans to resubmit the BLA later this year, after vaccine efficacy data from the ongoing Phase 3 trial of its investigational seasonal influenza vaccine, mRNA-1010, are available. Moderna continues to expect interim data from the mRNA-1010 trial to be available this summer.
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab
PPN Expands Influence in Pharmacy Media with New Hosting Platform and June Podcast Lineup
Pharmacy Podcast Network Unveils New Host Membership & Analytics Platform, Announces Four New Podcast Launches for June
ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health
Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures
Mother of Combs's ex Cassie testifies at music mogul's trial
The mother of Sean "Diddy" Combs's ex-partner Cassie testified Tuesday about threats and violence experienced by her daughter during her decade-long relationship with the music mogul.
Women's Champions League trophy recovered by police after theft
Portuguese police announced Tuesday the recovery of the Women's Champions League trophy after it was stolen from the Estadio Jose Alvalade in Lisbon, which will host the upcoming final between holders Barcelona and Arsenal.
Family mourns Mexican naval cadet killed in New York bridge crash
The father of one of two Mexican cadets killed when a naval sailing ship crashed into New York's Brooklyn Bridge paid tribute to his daughter as a "wonderful" person Tuesday.
Chess great Carlsen held to draw by 143,000 players
Chess legend Magnus Carlsen, considered one of the best players in history, has been held to a draw by a team of 143,000 opponents in an online match.
Germany reports 40% jump in politically motivated crime
Germany saw a 40 percent jump in politically motivated crime last year, official data showed Tuesday, with the federal police chief warning of a growing "radicalisation in society".
Mother of jailed Egyptian-UK activist returns to full hunger strike
The mother of jailed Egyptian-British activist Alaa Abdel Fattah announced on Tuesday that she was returning to a full hunger strike to protest against her son's lengthy imprisonment in Egypt.
Gazan twins in Cannes warn 'nothing left' of homeland
Twin Gazan filmmakers Arab and Tarzan Nasser said they never thought the title of their new film "Once Upon A Time In Gaza" would have such heartbreaking resonance.
Dr. Vinson Eugene Allen Expands Dusk to Dawn Urgent Care to the Residents of Lancaster, California
Dusk to Dawn Urgent Care Opens New Location in Lancaster
Utah Author Wins Gold Twice in National Book Competition
Upset Victory at the IBPA Book Awards
First Patient Randomized in Jaguar Health’s Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
As announced, initial proof-of-concept (POC) results from distinct ongoing investigator-initiated trial (IIT) in Abu Dhabi show crofelemer reduced total parenteral support in a pediatric MVID patient with intestinal failure by up to 27%; per the IIT protocol, patient was taken off crofelemer after 12 weeks of treatment for a period of 30 days, but was restarted on daily crofelemer treatment after just 8 days, as patient's symptoms were worseningAdditional POC IIT results expected throughout 2025 for MVID; results from company's MVID Phase 2 study expected with completion of treatment in H2 2026Ground-breaking results in single-digit number of MVID patients could potentially lead to expedited approval in the EU through PRIME and to Breakthrough Therapy designation in the US
Dolphin Subsidiary Special Projects Curates Star-Studded Guest List for the Tory Burch Store Opening on Rodeo Drive
A-List attendees included Ciara, Kate Hudson, Rachel Brosnahan, Rashida Jones, Jodie Turner-Smith, and many more
Shane Osborn Appointed Chief Operating Officer of Ocean Thermal Energy Corporation
PHILADELPHIA, PA / ACCESS Newswire / May 20, 2025 / Ocean Thermal Energy Corporation (OTE Corp), a leading renewable energy company specializing in Ocean Thermal Energy Conversion (OTEC) and Seawater Air Conditioning (SWAC), is pleased to announce the appointment of Shane Osborn as its new Chief Operating Officer (COO).
M2i Global, Inc. Appoints Former President Trump Appointee Peter O'Rourke as Senior Advisor
Brings Executive Perspective and Relationships in U.S. Government and Defense
Iraq's First Fully Solar-Powered Village in Kulak Is Now Operational
ERBIL, IRAQ / ACCESS Newswire / May 20, 2025 / The Erbil-based Rwanga Foundation is proud to announce the completion and official launch of the Kulak Solar Village, Iraq's first fully off-grid, solar-powered community. This transformative project marks a new chapter in sustainable development and climate resilience for both the Kurdistan region and Iraq as a whole.
Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Trial marks key milestone in driving pipeline progressPhase 1 trial scheduled for completion mid-June 2025Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback
Hear At Last Holdings Receives Initial Purchase Order of Portable Homes from Jamaican Developer
TORONTO, ON / ACCESS Newswire / May 20, 2025 / Hear At Last Holdings Inc., an emerging player in modular and portable housing solutions, is pleased to announce the receipt of an initial purchase order from a leading Jamaican real estate developer for its innovative line of portable homes.
MD&M East Explores AI and Automation Shaping the Future of Manufacturing and MedTech
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / MD&M East, the region's largest event for the engineering sector, returns May 20-22, 2025, to Jacob K. Javits Convention Center in New York City bringing together over 300 exhibitors across MedTech, packaging, plastics, design & manufacturing, automation and quality. Attendees can expect to see live demos, product launches and the latest innovation in smart manufacturing, design engineering and regulatory solutions, all under one roof.
Interactive Strength Inc. (Nasdaq:TRNR) Reiterates $75M Guidance, Expected Profitability in Q4 on Adjusted EBITDA Basis Due to Pending Sportstech, Wattbike Deals
Company Updates Investor Presentation to Reflect Strong Q1 Earnings, More than $20M in Pro Forma Revenue and 15% Increase in 2025 Pro Forma Revenue Guidance
CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
TÜBINGEN, GERMANY and BOSTON, MA / ACCESS Newswire / May 20, 2025 / CureVac N.V. (Nasdaq:CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced financial results for the first quarter of 2025 and provided a business update.
FBC Holding, Inc. (FBCD) Apparel Worn by Pro Athletes as Formrunner Gains Traction in Sports Culture
Global streetwear market expected to surpass $220 billion by 2032 as limited drops and athlete interest drive demand for emerging brands.
Why Are DEA’s Prevoznik and Strait Lecturing the World on Drug Policy While Undermining U.S. Marijuana Law?
The appearance of Thomas Prevoznik and Matthew Strait as thought leaders in global drug policy is more than just tone-deaf-it's dangerous. It validates a failed regulatory approach that punishes innovation, undermines public health, and sidelines scientific progress for political convenience
Brazil's ousted football president paves way for succession
Ednaldo Rodrigues, the deposed former president of the Brazilian Football Confederation (CBF), withdrew his appeal Monday to Brazil's Supreme Court seeking to overturn his ousting, clearing the way for his successor in upcoming elections.
Trump signs bill outlawing 'revenge porn'
US President Donald Trump signed a bill on Monday making it a federal crime to post "revenge porn" -- whether it is real or generated by artificial intelligence.